Mr. Thorburn will serve as the Company’s principal accounting officer until a successor to Mr. Yankton is appointed, in addition to his current role as the Company’s Chief Financial Officer.
On March 23, 2023, Kevin Yankton, Chief Accounting Officer of Twist Bioscience Corporation (the “Company”), provided notice of his resignation from the Company effective May 19, 2023, to pursue other interests.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
James Thorburn was appointed as Principal Accounting Officer at Twist Bioscience Corp.
Action
appointed
Role
Principal Accounting Officer
Exact text from the filing
Mr. Thorburn will serve as the Company’s principal accounting officer until a successor to Mr. Yankton is appointed, in addition to his current role as the Company’s Chief Financial Officer.
Kevin Yankton resigned as Chief Accounting Officer at Twist Bioscience Corp.
Action
resigned
Role
Chief Accounting Officer
Exact text from the filing
On March 23, 2023, Kevin Yankton, Chief Accounting Officer of Twist Bioscience Corporation (the “Company”), provided notice of his resignation from the Company effective May 19, 2023, to pursue other interests.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.